Kurt R. Brekke is Professor at the Department of Economics at the Norwegian School of Economics (NHH) since 2009. He is also Head of the Center for Business Economics (CBE) at NHH.
Brekke was Chief Economist at the Norwegian Competition Authority for the period 2016-2020. Prior to that he was Head of the IO and competition policy program at the SNF Center for Applied Research at NHH (2014-16) and Co-manager of the BECCLE Bergen Center for Competition Law and Competition Economics (2014-16). Brekke has also been associate editor for the Journal of Economic Behavior & Organization (2011-6), member of the Governmental Committee on National Public Procurement Regulation (2012-2014), and is research fellow at the CESifo institute and BECCLE.
His research interests are in the field of industrial organization with a particular focus on the markets for healthcare and pharmaceuticals. He has written several book chapters and research reports, and published extensively in international academic journals, including Journal of Public Economics, Journal of Health Economics, Journal of Economics & Management Strategy, Journal of Economic Behavior & Organization, Regional Science & Urban Economics, European Economic Review, Scandinavian Journal of Economics.
Brekke received a PhD in Economics from the University of Bergen in 2003.
|Brekke, Kurt Richard; Holmås, Tor Helge; Monstad, Karin; Straume, Odd Rune||Do treatment decisions depend on physicians' financial incentives?||Journal of Public Economics Volume 155; page 74 - 92; 2017|
|Brekke, Kurt Richard; Pires, Armando; Schindler, Dirk; Schjelderup, Guttorm||Capital taxation and imperfect competition: ACE vs. CBIT||Journal of Public Economics Volume 147; page 1 - 15; 2017|
|Brekke, Kurt Richard; Siciliani, Luigi; Straume, Odd Rune||Hospital Mergers with Regulated Prices||The Scandinavian Journal of Economics Volume 119 (3); page 597 - 627; 2017|
|Brekke, Kurt; Holmås, Tor Helge; Straume, Odd Rune||Margins and market shares: Pharmacy incentives for generic substitution||European Economic Review Volume 61; page 116 - 131; 2013|
|Brekke, Kurt; Holmås, Tor Helge; Straume, Odd Rune||Reference pricing, competition, and pharmaceutical expenditures: theory and evidence from a natural experiment||Journal of Public Economics Volume 95 (7-8); page 624 - 638; 2011|
|Brekke, Kurt; Siciliani, Luigi; Straume, Odd Rune||Hospital Competition and Quality with Regulated Prices||The Scandinavian Journal of Economics Volume 113 (2); page 444 - 469; 2011|
|Brekke, Kurt R.; Nuscheler, Robert; Straume, Odd Rune||Quality and location choices under price regulation||Journal of Economics and Management Strategy Volume 15 (1); page 207 - 227; 2006|
|Brekke, Kurt R.; Kuhn, Michael||Direct to consumer advertising in pharmaceutical markets||Journal of Health Economics Volume 25 (1); page 102 - 130; 2006|
Research in progress
- "Hospital competition in the National Health Service: Evidence from a patient choice reform" (with C Canta, L Siciliani and OR Straume) Revise and resubmit in Journal of Health Economics
- "Does reference pricing drive out generic competition in pharmaceutical markets? Evidence from a policy reform" (with C Canta and OR Straume)
- “How to pay for drugs?” (with DM Dalen og OR Straume)
Competition Analysis, Industrial organisation
Brekke, K. R. & Straume, O. R. (2020, 9. august). Netflix-prising av legemidler kan ha birivkninger, Dagens Næringsliv.
Brekke, K. R. & Straume, O. R. (2020, 5. august). Netflix-metoden er neppe rett medisin, Dagens Næringsliv.
Svendsen, S. A. & Brekke, K. R. (2020, 8. juli). Ikke sett konkurransen på spill, Dagens Næringsliv.
Brekke, K. R. (2020, 28. januar). Vi har ikke amerikanske "monopoltendenser" i norsk økonomi, Dagens Næringsliv.
Høiland, J. K. & Brekke, K. R. (2020, 23. januar). Feil behandling av legemiddelmangel, Dagens Medisin.
Brekke, K. R. (2019, 6. desember). Vi trenger flere leger, ikke dyrere leger, Dagens Næringsliv.
Brekke, K. R. (2019, 23. januar). Fastleger på fastlønn er neppe løsningen, Dagens Næringsliv.
Brekke, K. R. (2018, 20. oktober) Vi får mer medisin for pengene, Bergens Tidende.
Brekke, K. R. & Reiso, K. (2018, 29. juli). Roboter, pris og fremtidens kartell, Dagens Næringsliv.
Brekke, K. R. (2017, 4. mars). Gigantkonsern er feil medisin, Dagens Næringsliv